glp 1 agonists addiction Substance use disorders (SUDs) may become the next therapeutic target for GLP-1 receptor (GLP-1s). Although the evidence remains preliminary, growing preclinical, observational, and early clinical data suggest these drugs may reduce GLP-1s Like Ozempic May Be

Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK

20.1 min, 35% B

Since the data extracted from the VAL databases was individual-level data, it was also possible to link the registers, thus connecting preexisting diagnosis and treatment to individual patients dispensed a GLP-1 RA

Vacratsis, Panayiotis O

The effectiveness of any patch depends on the specific ingredients and whether they can penetrate the skin barrier effectively

Moreover, the high heterogeneity of MM remains a major obstacle, and currently, there is a lack of validated biomarkers to predict ferroptosis sensitivity, limiting precise therapeutic stratification